GGrantIndex
Sort

21,281 grants matching influenza

Training in the Design and Development of Infectious Disease Therapeutics

$181,122
Stephen W White · St. Jude Children'S Research Hospital · T32 · FY2016 · AI

Software Development & Core Facilities

$181,046
Alessandro Vespignani · Fred Hutchinson Cancer Research Center · U54 · FY2014 · GM

Training in Immunology

$181,046
Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · T32 · FY2011 · AI

Reducing Transmission of Influenza by Face Masks

$181,000
Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2008 · CI

EAGER: Collaborative Research: Combining Community and Clinical Data for Augmenting Influenza Modeling

$180,877
Rumi Chunara · New York University · · FY2016 · CSE

STRUCTURE/FUNCTION OF THE INFLUENZA VIRUS GENOME

$180,875
Northwestern University · R37 · FY2001 · AI

Determining SARS-CoV host gene requirements by mutagenesis and RNA interface

$180,872
Robert J Hogan · University Of Georgia · R21 · FY2008 · AI

Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings

$180,777
Gayani Tillekeratne · Duke University · K23 · FY2020 · AI

Evolution and biology of Influenza B viruses in pigs

$180,759
Wenjun Ma · Kansas State University · R21 · FY2018 · AI

SMART Arrays for Pathogen Detection

$180,734
Tiffani Anne Greene · Integral Molecular · R43 · FY2006 · AI

The Role of Natural Human Anergic B cells in Systemic Lupus Erythematosus Patholo

$180,734
Patrick Christopher Wilson · University Of Chicago · U19 · FY2011 · AI

Rapid Generation of Human Therapuetic Antibodies Against Influenza

$180,667
Brian Curtis Turner · Taiga Biotechnologies, Inc. · R43 · FY2008 · AI

Core A: Administrative

$180,626
Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI

Single-cycle infectious Zika viruses for the development of a live-attenuated vaccine

$180,457
Luis Martinez-Sobrido · University Of Rochester · R21 · FY2017 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$180,430
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2021 · AI

Vaccine Treatment and Evaluation Unit: Phase I Influenza Vaccine Clinical Trial

$180,390
Clarence Buddy Creech · Vanderbilt University · N01 · FY2019 · AI

Uncovering and Addressing Cultural Beliefs Behind Vaccine Racial Disparities

$180,374
Sandra Crouse Quinn · Univ Of Maryland, College Park · P20 · FY2016 · MD

Innate Immune Control of Influenza Virus Infection

$180,373
Kevin L Legge · University Of Iowa · R21 · FY2008 · AI

Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's

$180,363
Robert K Ernst · University Of Maryland Baltimore · R21 · FY2013 · AI

Immunogenicity of Subunit Vaccine Delivered by FcRn

$180,242
Xiaoping Zhu · Univ Of Maryland, College Park · R21 · FY2007 · AI

STRUCTURE/FUNCTION OF BACTERIAL ADHESION PILI

$180,202
Boston University Medical Campus · R01 · FY2001 · GM

Anti viral function of interferon alpha induced human beta defensin 3

$180,200
Santanu Bose · University Of Texas Hlth Science Center · R21 · FY2007 · AI

Visualizing Interferon-beta Induction In Vivo

$180,000
Joan E. Durbin · Research Inst Nationwide Children'S Hosp · R21 · FY2008 · AI

Sustaining Influenza Surveillance Networks and Response to Seasonal

$180,000
Khatuna Zakhashvili · National Center/Disease Ctrl/Med Stats · U51 · FY2015 · IP

Sustaining National Influenza Surveillance and Response to Seasonal

$180,000
Julius Julian Lutwama · Uganda Virus Research Institute · U51 · FY2015 · IP